This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Ascentawits Pharmaceuticals, Ltd., Shenzhen Haibin Pharmaceutical Co., Ltd.. Active years: 2015-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2026
Title: Yanjun Zhang: Innovator in Pharmaceutical Chemistry
Introduction
Yanjun Zhang is a notable inventor based in Shenzhen, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of intermediate compounds for antibiotic production. His work is characterized by a focus on efficiency and cost-effectiveness in drug manufacturing.
Latest Patents
Yanjun Zhang holds a patent for a doripenem intermediate compound, which is crucial for the preparation of the antibiotic doripenem. The patent describes a novel compound represented by formula (XIV), where PNB is p-nitrobenzyl, and HX is an acid. The invention outlines a straightforward process for synthesizing this intermediate compound, which enhances yield and reduces production costs. The new mono-protected doripenem intermediate simplifies the de-protection step through catalytic hydrogenation, making it suitable for industrial production.
Career Highlights
Zhang is associated with Shenzhen Haibin Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical development. His innovative approach has led to advancements in the production processes of important medications, contributing to the efficiency of the pharmaceutical industry.
Collaborations
Yanjun Zhang collaborates with talented professionals in his field, including Peng Ren and Lisong Long, who contribute to his research and development efforts. Their teamwork fosters an environment of innovation and progress in pharmaceutical chemistry.
Conclusion
Yanjun Zhang's contributions to the field of pharmaceutical chemistry, particularly through his patent on doripenem intermediate compounds, highlight his role as an innovator. His work not only advances drug production but also emphasizes the importance of efficiency in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile